Journal of pain & palliative care pharmacotherapy
-
J Pain Palliat Care Pharmacother · Jan 2008
Access to pain relief: an essential human right. A report for World Hospice and Palliative Care Day 2007. Help the hospices for the Worldwide Palliative Care Alliance.
In observance of World Hospice and Palliative Care Day, October 6, 2007, the Worldwide Palliative Care Alliance developed a comprehensive publication advocating access to pain relief as a basic human right. The British Charity help the Hospices distributed this publication, which describes the current state of pain relief in advanced disease throughout the world, availability and lack of access to opioid analgesics, clinical case examples of how pain can be managed, governmental and private initiatives and barriers to pain relief, and statistics to support the position that pain relief is a basic human right.
-
J Pain Palliat Care Pharmacother · Jan 2008
Paying for complementary and alternative medicine treatment: information for patients. National Center for Complementary and Alternative Medicine National Institutes of Health.
This report is adapted from a fact sheet published on-line by the National Center for Complementary and Alternative Medicine (CAM) of the National Institutes of Health. The information is intended for patients considering CAM and who need information on how such services can be paid for or the patients and families reimbursed for the costs of CAM therapy.
-
J Pain Palliat Care Pharmacother · Jan 2008
Evidence-based pain management and palliative care in Issue One for 2008 of the Cochrane Library.
The Cochrane Library is published quarterly. Issue 1, 2008, contains 3,385 complete reviews, 1,786 protocols for reviews in production, and 7,048 one-page summaries of systematic reviews published in the general medical literature. ⋯ The health technology assessment database contains 7,177 citations. This edition of the Library contains 86 new reviews of which 7 have potential relevance for practitioners in pain and palliative medicine.
-
J Pain Palliat Care Pharmacother · Jan 2008
Is the DEA's new "prescription series" regulation balanced?
To address the dual public health imperatives of enhanced pain management and decreased abuse and diversion of prescription medications, the U. S. ⋯ The DEA later explicitly confirmed that they did not intend to impose undue limits on practice. Rather, if implemented appropriately, the new regulation can be considered an important mechanism to control medication diversion while maintaining access for legitimate medical purposes and patient care.
-
Progress in our understanding of the roles of genetics in pain and its management is described. New techniques are discussed, along with some potential uses of gene therapy. Relative gene expression, polymorphisms, and specific genes that influence interindividual responses to pharmacotherapy for pain are described.